945
Participants
Start Date
June 11, 2013
Primary Completion Date
August 1, 2016
Study Completion Date
April 19, 2024
Nivolumab
Ipilimumab
Placebo for Nivolumab
Placebo for Ipilimumab
Local Institution - 0032, Galway
Local Institution - 0036, Dublin
Local Institution - 0189, Lausanne
Local Institution - 0145, Vienna
Local Institution - 0003, Brussels
Local Institution - 0029, Auckland
Local Institution - 0002, Brussels
Local Institution - 0164, Geneva
Local Institution - 0017, Camperdown
Local Institution - 0138, North Sydney
Local Institution - 0023, Macquarie University
Local Institution - 0028, Gateshead
Local Institution - 0031, Coffs Harbour
Local Institution - 0004, Edegem
Local Institution - 0078, Herlev
Local Institution - 0026, Melbourne
Local Institution - 0103, Leuven
Local Institution - 0016, Heidelberg
Local Institution - 0024, Box Hill
Local Institution - 0018, Woolloongabba
Local Institution - 0019, Brisbane
Local Institution - 0022, Southport
Local Institution - 0020, Adelaide
Local Institution - 0077, Odense
Local Institution - 0148, Salzburg
Local Institution - 0025, Kurralta Park
Local Institution - 0021, Nedlands
Local Institution - 0163, Zurich
Local Institution - 0076, Aarhus
Local Institution - 0005, Ghent
Local Institution - 0186, Sankt Gallen
Local Institution - 0174, New York
Local Institution - 0070, New York
Local Institution - 0079, Albany
Local Institution - 0126, Marseille
Local Institution - 0069, Pittsburgh
Local Institution - 0115, Genova
Local Institution - 0112, Bethlehem
Local Institution - 0061, Allentown
Local Institution - 0098, Washington D.C.
Local Institution - 0183, Washington D.C.
Local Institution - 0172, Milan
Local Institution - 0117, Milan
Local Institution - 0080, Lutherville
Local Institution - 0162, Buxtehude
Local Institution - 0158, Kiel
Local Institution - 0176, Bergamo
Local Institution - 0048, Durham
Local Institution - 0150, Madrid
Local Institution - 0149, Madrid
Local Institution - 0047, Charlotte
Local Institution - 0153, Málaga
Local Institution - 0154, Greenville
Local Institution - 0051, Atlanta
Local Institution - 0159, Hanover
Local Institution - 0147, Pamplona
Local Institution - 0042, Jacksonville
Local Institution - 0008, Orlando
Local Institution - 0169, Tampere
Local Institution - 0127, Rennes
Local Institution - 0062, Nashville
Local Institution - 0064, Nashville
Local Institution - 0065, Jackson
Local Institution - 0056, Nantes
Local Institution - 0007, Cleveland
Local Institution - 0156, Essen
Local Institution - 0113, Meldola (FC)
Local Institution - 0087, Ann Arbor
Local Institution - 0121, Tel Litwinsky
Local Institution - 0116, Siena
Local Institution - 0187, Minneapolis
Local Institution - 0067, St Louis
Local Institution - 0157, Heidelberg
Local Institution - 0124, Pierre-Bénite
Local Institution - 0134, Tübingen
Local Institution - 0044, Dallas
Texas Oncology, Dallas
Local Institution - 0058, Paris
Local Institution - 0088, Houston
Local Institution - 0052, Aurora
Local Institution - 0114, Napoli
Local Institution - 0160, München
Local Institution - 0089, Salt Lake City
Local Institution - 0085, Gilbert
University of Arizona Cancer Center, Tucson
Local Institution - 0068, Albuquerque
Local Institution - 0015, Las Vegas
Local Institution - 0053, Los Angeles
Local Institution - 0014, Los Angeles
Local Institution - 0171, Erlangen
Local Institution - 0120, Jerusalem
Local Institution - 0125, Boulogne-Billancourt
Comprehensive Cancer Center At Desert Regional Medical Ctr, Palm Springs
Local Institution - 0066, Rancho Mirage
California Pacific Medical Center Research Institute, San Francisco
Local Institution - 0049, San Francisco
Local Institution, Villejuif
Local Institution - 0045, Portland
Local Institution - 0054, Seattle
Local Institution - 0161, Erfurt
Local Institution - 0130, Moscow
Local Institution - 0132, Saint Petersburg
Local Institution - 0128, Saint Petersburg
Local Institution - 0131, Samara
Local Institution - 0046, La Jolla
Local Institution - 0084, New Haven
Maine Center For Cancer Medicine, Scarborough
Local Institution - 0081, Boston
Local Institution - 0082, Boston
Local Institution - 0083, Boston
Local Institution - 0188, Morristown
Local Institution - 0140, Edmonton
Local Institution - 0165, Vancouver
Local Institution - 0141, London
Local Institution - 0143, Ottawa
Local Institution - 0166, Toronto
Local Institution - 0139, Montreal
Local Institution - 0142, Québec
Local Institution - 0092, Brno
Local Institution - 0091, Hradec Králové
Local Institution - 0090, Prague
Local Institution - 0167, Prague
Local Institution - 0071, Helsinki
Local Institution - 0178, Leipzig
Local Institution - 0035, Dublin
Local Institution - 0034, Dublin
Local Institution - 0033, Cork
Local Institution - 0168, Dublin
Local Institution - 0118, Padua
Local Institution - 0177, Roma
Local Institution - 0010, Amsterdam
Local Institution - 0012, Leiden
Local Institution - 0013, Nijmegen
Local Institution - 0123, Oslo
Local Institution - 0109, Gdansk
Local Institution - 0133, Krakow
Local Institution - 0060, Lodz
Local Institution - 0059, Warsaw
Local Institution - 0152, Badalona-Barcelona
Local Institution - 0151, Barcelona
Local Institution - 0175, Barcelona
Local Institution - 0182, Gothenberg
Local Institution - 0184, Stockholm
Local Institution - 0039, Glasgow
Local Institution - 0038, London
Local Institution - 0119, Manchester
Local Institution - 0041, Northwood
Local Institution - 0122, Nottingham
Local Institution - 0037, Cambridge
Local Institution - 0040, Swansea
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY